Common Stock, Shares, Outstanding of Quince Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Quince Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Quince Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 54,494,965, a 26% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Quince Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 54,494,965 +11,218,359 +26% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 53,624,180 +10,347,574 +24% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 44,089,142 +873,909 +2% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 44,001,643 +1,028,428 +2.4% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 43,276,606 +6,932,974 +19% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 43,276,606 +6,948,611 +19% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 43,215,233 +6,936,800 +19% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 42,973,215 +6,836,735 +19% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 36,343,632 +213,326 +0.59% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 36,327,995 +350,307 +0.97% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 36,278,433 +6,128,863 +20% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 36,136,480 +6,062,068 +20% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 36,130,306 +6,263,043 +21% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 35,977,688 +6,321,902 +21% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 30,149,570 +573,626 +1.9% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 30,074,412 +531,190 +1.8% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 29,867,263 +373,014 +1.3% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 29,655,786 +169,517 +0.58% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 29,575,944 +171,404 +0.58% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 29,543,222 +2,673,809 +10% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 29,494,249 +2,653,100 +9.9% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 29,486,269 +2,645,120 +9.9% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 29,404,540 +25,837,617 +724% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 26,869,413 +23,457,047 +687% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 26,841,149 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 26,841,149 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 3,566,923 31 Mar 2019 10-Q 12 Jun 2019 2019 Q1
Q4 2018 3,412,366 31 Dec 2018 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.